Results 91 to 100 of about 118,029,531 (234)
ABSTRACT Preoperative diagnosis of ductal carcinoma in situ (DCIS) may be followed by pathological upstaging to invasive ductal carcinoma (IDC) upon surgical excision, a discrepancy that significantly impacts surgical planning and decisions regarding sentinel lymph node biopsy (SLNB).
Yu‐Hua Chen +5 more
wiley +1 more source
Ductal Carcinoma In Situ: A Clinical Conundrum
Before the advent of breast cancer screening programs, ductal carcinoma in situ (DCIS) comprised only 2% to 5% of symptomatic cancers, and presentation as a palpable mass was extremely uncommon...
John R Benson (16266674) +1 more
core
This pictorial essay demonstrates the variable appearances of ductal carcinoma in situ on full-field digital mammography, synthesized mammography, and digital breast tomosynthesis.
Laurie R. Margolies +3 more
core +1 more source
Core Needle Biopsy in the Diagnosis of Major Salivary Gland Tumors
In this retrospective study, the diagnostic utility and reliability of CNB were evaluated in 247 CNB samples obtained from 217 patients with major salivary gland lesions, including both surgically confirmed lesions and conservatively managed cases. High diagnostic accuracy was demonstrated for CNB in the evaluation of major salivary gland lesions, and ...
Mira Naukkarinen +6 more
wiley +1 more source
CARCINOMA DUCTAL IN SITU: GENERALIDADES, DIAGNÓSTICO, TRATAMIENTO Y CONTROVERSIAS
El carcinoma ductal in situ (CDIS) constituye, en lugar de una sola entidad, un grupo heterogéneo de lesiones con diferente potencial de malignidad y se lo considera un verdadero precursor del cáncer.
Carlos E Muñoz Medina +8 more
doaj +2 more sources
Patterns of Chromosomal Alterations in Breast Ductal
Purpose: Ductal carcinoma in situ (DCIS) is thought to be a nonobligate precursor of invasive cancer. Genomic changes specific to pure DCIS versus invasive cancer, as well as alterations unique to individual DCIS subtypes, have not been fully ...
Frederic M. Waldman +8 more
core
Data‐Independent Acquisition Mass Spectrometry in Tumor Classification and Cancer Biomarker Research
Abstract Cancer treatment is far from optimal also because current classification systems do not reflect the complex molecular status of the tumor and its phenotype in sufficient detail. To construct molecular tumor classifiers, omics tools provide complex molecular data reflecting many aspects from genotype to phenotype.
Jan Simonik +3 more
wiley +1 more source
The natural history of the patients of ductal carcinoma in situ(DCIS) with microinvasion is poorly defined, and the clinical management of these patients with particular reference to management of the axilla, has been controversial.
박병우
core
Supplementary Data from MNK1/NODAL Signaling Promotes Invasive Progression of Breast Ductal Carcinoma In ...
Lynne-Marie Postovit (123317) +28 more
core +1 more source

